MOHAMED KISHORI: Open Payments
NPI 1962610741 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$214 in 8 payments from 5 companies in 2025. Trend: 2023 $141 · 2024 $273 · 2025 $214
Food & beverage: $214
| Company | Payments | Amount |
|---|---|---|
| UROGEN PHARMA, INC. | 2 | $68 |
| ABBVIE INC. | 2 | $53 |
| Endo USA, Inc. | 2 | $46 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: JELMYTO, XIAFLEX, LUPRON DEPOT, MAVYRET, GEMTESA, Xtandi.
Industry payments across NY — which companies pay providers there.
